Castle Biosciences Inc
NASDAQ:CSTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Castle Biosciences Inc
NASDAQ:CSTL
|
US |
|
Patterson-UTI Energy Inc
NASDAQ:PTEN
|
US |
|
Pebblebrook Hotel Trust
NYSE:PEB
|
US |
|
M
|
Marti Technologies Inc
AMEX:MRT
|
US |
|
Lockheed Martin Corp
NYSE:LMT
|
US |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
US |
|
W
|
Weiqiao Textile Co Ltd
HKEX:2698
|
CN |
|
Primo Water Corp
TSX:PRMW
|
US |
|
Airtel Africa PLC
LSE:AAF
|
UK |
|
B
|
BlackRock Inc
F:UU2
|
US |
|
Clariane SE
PAR:CLARI
|
FR |
|
Amtech Systems Inc
NASDAQ:ASYS
|
US |
|
Birkenstock Holding PLC
NYSE:BIRK
|
UK |
|
E
|
Energy SpA
MIL:ENY
|
IT |
|
East Japan Railway Co
TSE:9020
|
JP |
|
I
|
Industrie De Nora SpA
MIL:DNR
|
IT |
|
Curtis Banks Group PLC
LSE:CBP
|
UK |
|
Star Bulk Carriers Corp
NASDAQ:SBLK
|
GR |
|
Microchip Technology Inc
NASDAQ:MCHP
|
US |
|
Nexgen Energy Ltd
TSX:NXE
|
CA |
|
ConvaTec Group PLC
LSE:CTEC
|
UK |
Wall St Price Targets
CSTL Price Targets Summary
Castle Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
CSTL is 48.07 USD with a low forecast of 40.4 USD and a high forecast of 54.6 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CSTL's stock price target?
Price Target
48.07
USD
According to Wall Street analysts, the average 1-year price target for
CSTL is 48.07 USD with a low forecast of 40.4 USD and a high forecast of 54.6 USD.
What is the Revenue forecast for Castle Biosciences Inc?
Projected CAGR
7%
Over the last 7 years, the compound annual growth rate for Revenue has been 47%. The projected CAGR for the next 8 years is 7%.